Home

Julie Jordan, Chief Medical Officer: Neurogene NGNE Sell · Filed 03/30

Trade details

Type
Insider sale
Amount
$18,124.92
Shares · price
828 sh · $21.89 a share
Held after
12,472 sh
Trade date
26/03/26
Filed
26/03/30
Days to filing
4 days

Sold 6.2% of holdings

Share of holding sold
6.2%

Neurogene trades, last 26 weeks

What else happened in Neurogene around then

Filed or reported within 30 days of the trade day · 02/24~04/25

Julie Jordan's recent trades

  • Julie Jordan

    Sell10b5-1 planQ32 Bio

    $1,818

    Filed 23/08/07

  • Julie Jordan

    Sell10b5-1 planQ32 Bio

    $152

    Filed 23/08/07

  • Julie Jordan

    Sell10b5-1 planQ32 Bio

    $606

    Filed 23/08/07

  • Julie Jordan

    Sell10b5-1 planQ32 Bio

    $130

    Filed 23/08/04

Julie Jordan, Chief Officer — sold $18.1K of Neurogene NGNE · 6.2% of holdings · 10b5-1 plan | Whalegun